These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The efflux pump inhibitor phenylalanine-arginine β-naphthylamide (PAβN) increases resistance to carbapenems in Chilean clinical isolates of KPC-producing Klebsiella pneumoniae. Vera-Leiva A; Carrasco-Anabalón S; Lima CA; Villagra N; Domínguez M; Bello-Toledo H; González-Rocha G J Glob Antimicrob Resist; 2018 Mar; 12():73-76. PubMed ID: 29275225 [TBL] [Abstract][Full Text] [Related]
3. Boosting the Antibacterial Activity of Azithromycin on Multidrug-Resistant Al-Marzooq F; Ghazawi A; Daoud L; Tariq S Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240007 [TBL] [Abstract][Full Text] [Related]
4. Modification of the susceptibility of gram-negative rods producing ESβLS to β-lactams by the efflux phenomenon. Laudy AE; Osińska P; Namysłowska A; Zając O; Tyski S PLoS One; 2015; 10(3):e0119997. PubMed ID: 25793625 [TBL] [Abstract][Full Text] [Related]
5. Effect of phenylalanine arginyl β-naphthylamide on the imipenem resistance, elastase production, and the expression of quorum sensing and virulence factor genes in Pseudomonas aeruginosa clinical isolates. Zolpirani FH; Ghaemi EA; Yasaghi M; Nikokar I; Ardebili A Braz J Microbiol; 2024 Sep; 55(3):2715-2726. PubMed ID: 38926315 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β-naphthylamide. Sonnet P; Izard D; Mullié C Int J Antimicrob Agents; 2012 Jan; 39(1):77-80. PubMed ID: 21974858 [TBL] [Abstract][Full Text] [Related]
7. Activity of the efflux pump inhibitor phenylalanine-arginine β-naphthylamide against the AdeFGH pump of Acinetobacter baumannii. Cortez-Cordova J; Kumar A Int J Antimicrob Agents; 2011 May; 37(5):420-4. PubMed ID: 21377839 [TBL] [Abstract][Full Text] [Related]
8. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG). Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815 [TBL] [Abstract][Full Text] [Related]
9. Importance of Real-Time Assays To Distinguish Multidrug Efflux Pump-Inhibiting and Outer Membrane-Destabilizing Activities in Escherichia coli. Misra R; Morrison KD; Cho HJ; Khuu T J Bacteriol; 2015 Aug; 197(15):2479-88. PubMed ID: 25962916 [TBL] [Abstract][Full Text] [Related]
10. Loss of membrane-bound lytic transglycosylases increases outer membrane permeability and β-lactam sensitivity in Pseudomonas aeruginosa. Lamers RP; Nguyen UT; Nguyen Y; Buensuceso RN; Burrows LL Microbiologyopen; 2015 Dec; 4(6):879-95. PubMed ID: 26374494 [TBL] [Abstract][Full Text] [Related]
11. Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability. Buyck JM; Plésiat P; Traore H; Vanderbist F; Tulkens PM; Van Bambeke F Clin Infect Dis; 2012 Aug; 55(4):534-42. PubMed ID: 22573850 [TBL] [Abstract][Full Text] [Related]
12. The Impact of Efflux Pump Inhibitors on the Activity of Selected Non-Antibiotic Medicinal Products against Gram-Negative Bacteria. Laudy AE; Kulińska E; Tyski S Molecules; 2017 Jan; 22(1):. PubMed ID: 28085074 [TBL] [Abstract][Full Text] [Related]
13. Efflux pump inhibitor, phenylalanine-arginine beta-naphthylamide analog potentiates the activity of 5-O-mycaminosyltylonolide for multi-drug resistant Pseudomonas aeruginosa. Kimishima A; Honsho M; Terai J; Wasuwanich P; Honma S; Matsui H; Hanaki H; Asami Y J Antibiot (Tokyo); 2024 May; 77(5):331-333. PubMed ID: 38467778 [TBL] [Abstract][Full Text] [Related]
14. Bark extract of Cassia sieberiana DC. (Caesalpiniaceae) displayed good antibacterial activity against MDR gram-negative phenotypes in the presence of phenylalanine-arginine β-naphthylamide. Ambadiang MMM; Atontsa BCK; Tankeo SB; Nayim P; Wamba BEN; Bitchagno GTM; Mpetga JDS; Penlap VB; Kuete V BMC Complement Med Ther; 2020 Nov; 20(1):342. PubMed ID: 33183278 [TBL] [Abstract][Full Text] [Related]
15. Control of quorum sensing and virulence factors of Pseudomonas aeruginosa using phenylalanine arginyl β-naphthylamide. El-Shaer S; Shaaban M; Barwa R; Hassan R J Med Microbiol; 2016 Oct; 65(10):1194-1204. PubMed ID: 27498852 [TBL] [Abstract][Full Text] [Related]
16. Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa. Hirakata Y; Kondo A; Hoshino K; Yano H; Arai K; Hirotani A; Kunishima H; Yamamoto N; Hatta M; Kitagawa M; Kohno S; Kaku M Int J Antimicrob Agents; 2009 Oct; 34(4):343-6. PubMed ID: 19615866 [TBL] [Abstract][Full Text] [Related]
17. Polyamine effects on antibiotic susceptibility in bacteria. Kwon DH; Lu CD Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056 [TBL] [Abstract][Full Text] [Related]
18. Scalable and Chromatography-Free Synthesis of Efflux Pump Inhibitor Phenylalanine Arginine β-Naphthylamide for Its Validation in Wild-Type Bacterial Strains. Russo CM; Howey KG; O'Reilly MC ChemMedChem; 2023 Jul; 18(14):e202300128. PubMed ID: 37126222 [TBL] [Abstract][Full Text] [Related]
19. [Effect of Phenylalanine-arginine-beta-naphthylamide to Ciprofloxacin Minimum Inhibitory Concentration Values and Expression of Efflux Pump System Genes in Acinetobacter baumannii Isolates]. Kaynak Onurdağ F; Kayış U; Ökten S Mikrobiyol Bul; 2021 Jul; 55(3):285-299. PubMed ID: 34416797 [TBL] [Abstract][Full Text] [Related]
20. Determination of the efflux pump-mediated resistance prevalence in Pseudomonas aeruginosa, using an efflux pump inhibitor. Tohidpour A; Najar Peerayeh S; Mehrabadi JF; Rezaei Yazdi H Curr Microbiol; 2009 Sep; 59(3):352-5. PubMed ID: 19554368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]